Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

127 trials with published results (26%)

Research Maturity

320 completed trials (65% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.9%

24 terminated out of 492 trials

Success Rate

93.0%

+6.5% vs benchmark

Late-Stage Pipeline

24%

118 trials in Phase 3/4

Results Transparency

40%

127 of 320 completed with results

Key Signals

127 with results93% success24 terminated

Data Visualizations

Phase Distribution

389Total
Not Applicable (155)
Early P 1 (5)
P 1 (42)
P 2 (69)
P 3 (75)
P 4 (43)

Trial Status

Completed320
Recruiting58
Not Yet Recruiting30
Unknown25
Terminated24
Active Not Recruiting16

Trial Success Rate

93.0%

Benchmark: 86.5%

Based on 320 completed trials

Clinical Trials (492)

Showing 20 of 20 trials
NCT07570394Not Yet RecruitingPrimary

BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA

NCT06511193Active Not RecruitingPrimary

Chronicling the COPD Patient Journey and Change in COPD Symptoms, Quality of Life and Exacerbations Following Initiation of Budenoside/Glycopyrronium/Formoterol [BGF]

NCT07568119Active Not Recruiting

Feasibility and Acceptance of SonoHeal for Airway Clearance and Preliminary Comparison With the Standard of Care

NCT07412418Not Yet Recruiting

Screening for Pulmonary Embolism Using Single-channel Electrocardiogram

NCT07561177Not ApplicableCompletedPrimary

High Velocity Nasal Insufflation Versus Non Invasive Ventilation in COPD Patients With Acute Hypercapnic Respiratory Failure

NCT07275359Phase 1Not Yet RecruitingPrimary

Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations

NCT07482033Not ApplicableNot Yet Recruiting

The Impact of Training on Self-Efficacy, Symptom Level, and Activities of Daily Living

NCT00843271Active Not RecruitingPrimary

Endothelial Dysfunction, Biomarkers, and Lung Function -Ancillary to MESA

NCT07539974Not ApplicableNot Yet RecruitingPrimary

Effect of Inspiratory Muscle Training on Diaphragm Function in COPD Patients

NCT07541053CompletedPrimary

Low Fat-free Mass in Prognosis of People With Chronic Obstructive Pulmonary Disease

NCT07307781RecruitingPrimary

Study of Patient With Frequent Exacerbations in Moscow

NCT07221981Active Not RecruitingPrimary

Study of Patient With Frequent COPD Exacerbations

NCT07536035Recruiting

Potential of Interface Care Models to Deliver More Appropriate Care to Patients With Acute Medical Illness

NCT07536178Not ApplicableNot Yet Recruiting

Lungs on Fire: Wildfire Smoke, Incident Diseases, Susceptible Populations, and Community Values in Canada

NCT05166889Phase 3CompletedPrimary

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations

NCT05158387Phase 3CompletedPrimary

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations.

NCT07380711RecruitingPrimary

Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes

NCT06883305Phase 3RecruitingPrimary

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

NCT06863246CompletedPrimary

Postural Control in Chronic Obstructive Pulmonary Disease

NCT06871670CompletedPrimary

Force Control in Chronic Obstructive Pulmonary Disease

Scroll to load more

Research Network

Activity Timeline